TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients

Resistance to radio and chemotherapy is one of the major drawbacks in the progression of head and neck squamous cell cancer (HNSCC) patients, evidencing the importance of finding optimum molecular prognosis markers to develop personalized treatment schedules. TGF-β effector TAK1 activity has been re...

全面介紹

書目詳細資料
Main Authors: Honorato-Cía, B. (Beatriz), Alcalde, J. (Juan), Martinez-Monge, R. (Rafael), Garcia-Foncillas, J. (Jesús), Zabalegui, N. (Natalia)
格式: info:eu-repo/semantics/article
語言:eng
出版: Libertas Academica 2012
主題:
在線閱讀:https://hdl.handle.net/10171/23495